Fuyi Liu

Hangzhou, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 20 publications

An ambispective, observational real-world study of tumor-treating fields for treatment of Chinese patients with newly diagnosed or recurrent/progressive glioblastoma.

An ambispective, observational real-world study of tumor-treating fields for treatment of Chinese patients with newly diagnosed or recurrent/progressive glioblastoma.

Journal: Neuro-oncology advances

Published: October 22, 2025

BRD9 inhibition overcomes oncolytic virus therapy resistance in glioblastoma.

BRD9 inhibition overcomes oncolytic virus therapy resistance in glioblastoma.

Journal: Cell reports. Medicine

Published: March 27, 2025

Publisher Correction: Targeting overexpressed antigens in glioblastoma via CAR T cells with computationally designed high-affinity protein binders.

Publisher Correction: Targeting overexpressed antigens in glioblastoma via CAR T cells with computationally designed high-affinity protein binders.

Journal: Nature biomedical engineering

Published: December 11, 2024

Identifying PLAUR as a Pivotal Gene of Tumor Microenvironment and Regulating Mesenchymal Phenotype of Glioblastoma.

Identifying PLAUR as a Pivotal Gene of Tumor Microenvironment and Regulating Mesenchymal Phenotype of Glioblastoma.

Journal: Cancers

Published: January 10, 2024

TIMP1 protects against blood-brain barrier disruption after subarachnoid haemorrhage by inhibiting ubiquitination of astrocytic β1-integrin.

TIMP1 protects against blood-brain barrier disruption after subarachnoid haemorrhage by inhibiting ubiquitination of astrocytic β1-integrin.

Journal: Stroke and vascular neurology

Published: October 28, 2023

RBBP6 maintains glioblastoma stem cells through CPSF3-dependent alternative polyadenylation.

RBBP6 maintains glioblastoma stem cells through CPSF3-dependent alternative polyadenylation.

Journal: Cell discovery

Published: September 05, 2023

Targeting overexpressed antigens in glioblastoma via CAR T cells with computationally designed high-affinity protein binders.

Targeting overexpressed antigens in glioblastoma via CAR T cells with computationally designed high-affinity protein binders.

Journal: Nature biomedical engineering

Published: August 21, 2023

Radiotherapy-Induced Astrocyte Senescence Promotes an Immunosuppressive Microenvironment in Glioblastoma to Facilitate Tumor Regrowth.

Radiotherapy-Induced Astrocyte Senescence Promotes an Immunosuppressive Microenvironment in Glioblastoma to Facilitate Tumor Regrowth.

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)

Published: July 07, 2023

Single-Cell Transcriptomics Reveals the Heterogeneity of the Immune Landscape of IDH-Wild-Type High-Grade Gliomas.

Single-Cell Transcriptomics Reveals the Heterogeneity of the Immune Landscape of IDH-Wild-Type High-Grade Gliomas.

Journal: Cancer immunology research

Published: March 09, 2023

Development of microRNA-based therapeutics for central nervous system diseases.

Development of microRNA-based therapeutics for central nervous system diseases.

Journal: European journal of pharmacology

Published: August 31, 2022

Matricellular protein tenascin C: Implications in glioma progression, gliomagenesis, and treatment.

Matricellular protein tenascin C: Implications in glioma progression, gliomagenesis, and treatment.

Journal: Frontiers in oncology

Published: June 22, 2022

Role of complement C1q/C3-CR3 signaling in brain injury after experimental intracerebral hemorrhage and the effect of minocycline treatment.

Role of complement C1q/C3-CR3 signaling in brain injury after experimental intracerebral hemorrhage and the effect of minocycline treatment.

Journal: Frontiers in immunology

Published: April 13, 2022

Showing 1-12 of 20

Last Updated: 09/26/2026